An open-label study of Xeloda [capecitabine] plus gemcitabine on tumor response in patients with locally advanced or metastatic pancreatic cancer
Phase of Trial: Phase II
Latest Information Update: 01 Oct 2015
At a glance
- Drugs Capecitabine (Primary) ; Gemcitabine (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors Roche
- 23 Feb 2010 Last checked against Roche record.
- 22 Jul 2008 Status changed from in progress to completed, as reported by Roche.
- 01 Jun 2006 New trial record.